FDA Inspection 722423 — Douglas G. Day, MD
The FDA completed an inspection of Douglas G. Day, MD on April 19, 2011 in Roswell, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 19, 2011
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Roswell, GA (United States)
Additional Details
Clinical Investigator (CI)